Stryker Corp. (SYK) Tops Q4 EPS by 1c; Reaffirms FY13 Outlook
Tweet
Share
E-mailGet Alerts SYK Hot Sheet
Price: $341.09 -1.76%
Financial Fact:
Operating income: 486M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Operating income: 486M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Stryker Corp. (NYSE: SYK) reported Q4 EPS of $1.14, $0.01 better than the analyst estimate of $1.13. Revenue for the quarter came in at $2.34 billion versus the consensus estimate of $2.27 billion.
Stryker Corp. reaffirms FY2013 EPS of $4.25-4.40, versus the consensus of $4.30.
For earnings history and earnings-related data on Stryker Corp. (SYK) click here.
Stryker Corp. reaffirms FY2013 EPS of $4.25-4.40, versus the consensus of $4.30.
For earnings history and earnings-related data on Stryker Corp. (SYK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- Brookfield Wealth Solutions Ltd. (BNT) Reports Q2 EPS of $0.07
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
